The latest research from Fore Pharma, US Neuropathic Pain Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Neuropathic Pain pipeline products, Neuropathic Pain epidemiology, Neuropathic Pain market valuations and forecast, Neuropathic Pain products sales and competitive landscape in the US.
The research is classified into nine sections – Neuropathic Pain overview including etiology, pathophysiology, and diagnosis, Neuropathic Pain treatment options, Neuropathic Pain pipeline products, Neuropathic Pain market analysis comprising of Neuropathic Pain epidemiology, key products marketed for Neuropathic Pain, market valuations and forecast, products sales and market shares.
Research Scope: - Neuropathic Pain Pipeline: Find out the products in clinical trials for the treatment of Neuropathic Pain by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products - Neuropathic Pain Epidemiology: Find out the number of patients diagnosed (prevalence) with Neuropathic Pain in the US - Neuropathic Pain Products: Identify key products marketed and prescribed for Neuropathic Pain in the US, including trade name, molecule name, and company - Neuropathic Pain Product Sales: Find out the sales revenues of Neuropathic Pain products, both branded and generics, in the US - Neuropathic Pain Market Valuations: Find out the market size for Neuropathic Pain products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020 - Neuropathic Pain Products Market Share: Find out the market shares for key Neuropathic Pain products in the US
Benefits of this Research: The research helps executives to - Support monitoring and reporting national Neuropathic Pain market analysis and sales trends - Track competitor drugs sales and market share in the US Neuropathic Pain market - Track competitive developments in Neuropathic Pain market and present key issues and learnings - Synthesize insights for Neuropathic Pain market and products to drive business performance - Answer key business questions about the Neuropathic Pain market - Evaluate commercial market opportunity assessment, positioning, and segmentation for Neuropathic Pain products - Supports decision making in R&D to long term marketing strategies
Our reports have been used by over 10K customers, including:
KEY FINDINGS The global cartilage repair market is projected to record a CAGR of 15.42% during the forecast period, 2021-2028. The factors fueling the market growth are the rising geriatric population, the increasing sports injuries, and the growing prevalence of obesity. MARKET INSIGHTS Cartilage...
Germany And Netherlands Medical Marijuana Market Size, Share & Trends Analysis Report By Product (Flower, Oil), By Application (Chronic Pain, Mental Disorder, Cancer), By Country, And Segment Forecasts, 2020 - 2027
Germany And Netherlands Medical Marijuana Market Growth & Trends
Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-infective, Chemotherapy), By Region, And Segment Forecasts, 2021 - 2028 Home Infusion Therapy Market Growth & Trends The global home infusion therapy market...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc and LG Life Sciences Ltd. The global erythropoietin (EPO) market is expected to decline from $1.01 billion in 2019 to $0.95 billion in 2020 at a compound annual growth rate (CAGR) of -6.27%. The decline...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, GlaxoSmithKline, Pfizer, Boehringer Ingelheim and F. Hoffmann-La Roche. The global protein inhibitors market is expected to decline from $59.66 billion in 2019 to $56.97 billion in 2020 at a compound annual growth rate (CAGR) of...
The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages,...
Laryngeal Mask Market Size, Share & Trends Analysis Report By Type (Disposable, Reusable), By Patient (Adult, Children), By End Use (Hospitals & Clinics, ASCs), By Region, And Segment Forecasts, 2020 - 2027
Laryngeal Mask Market Growth & Trends
The global laryngeal mask market size is expected...
The North America Wearable Patch Market would witness market growth of 10.41% CAGR during the forecast period (2020-2026). A wearable patch is alternately called electronic skin or smart patch. They are used to diagnosis, monitor diseases, and drug delivery. It is also helpful in maintaining the health of aging patients suffering from...
Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products.The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies...
In Vitro Diagnostic Reagent
Medical Devices Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.